Analysts Set CVS Health Corporation (NYSE:CVS) Price Target at $94.91

Shares of CVS Health Corporation (NYSE:CVS) have earned an average recommendation of “Moderate Buy” from the twenty-three ratings firms that are covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating and nineteen have issued a buy rating on the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $94.9091.

Several analysts recently issued reports on the stock. Royal Bank Of Canada restated an “outperform” rating on shares of CVS Health in a research report on Thursday, December 4th. Bank of America lowered their target price on CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a research report on Tuesday, January 27th. Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a research report on Monday, December 29th. Sanford C. Bernstein reaffirmed a “market perform” rating and set a $91.00 price objective on shares of CVS Health in a research report on Tuesday, January 6th. Finally, Argus cut their price objective on CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a research note on Wednesday, January 28th.

CVS Health Stock Up 2.2%

Shares of CVS Health stock opened at $79.74 on Monday. The company has a market cap of $101.44 billion, a price-to-earnings ratio of 57.78, a price-to-earnings-growth ratio of 0.83 and a beta of 0.49. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. The company’s 50 day moving average is $78.39 and its 200 day moving average is $77.29. CVS Health has a twelve month low of $58.35 and a twelve month high of $85.15.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The firm had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. During the same period last year, the business posted $1.19 EPS. The company’s revenue for the quarter was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Research analysts anticipate that CVS Health will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. CVS Health’s dividend payout ratio is 192.75%.

Hedge Funds Weigh In On CVS Health

A number of hedge funds have recently made changes to their positions in the business. Harbor Capital Advisors Inc. boosted its stake in CVS Health by 72.1% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares during the period. Caitong International Asset Management Co. Ltd boosted its position in shares of CVS Health by 407.2% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 281 shares during the last quarter. Swiss RE Ltd. bought a new stake in CVS Health in the fourth quarter worth $26,000. Mcguire Capital Advisors Inc. purchased a new stake in CVS Health during the fourth quarter valued at $28,000. Finally, Corundum Trust Company INC purchased a new position in shares of CVS Health in the 3rd quarter worth $29,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.